Clinical Trials Market in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials Market in Brazil

Clinical Trials Market in Brazil – Human Trials LATAM

Brazil has emerged as a prominent player in the global clinical trials market, showcasing immense potential and offering a conducive environment for cutting-edge medical research.

With its vast and diverse patient population, robust healthcare infrastructure, renowned research institutions, and a supportive regulatory framework, Brazil presents an attractive destination for sponsors and researchers looking to conduct clinical trials. In this blog post, we will delve into the thriving clinical trials market in Brazil, exploring its key strengths, notable trends, regulatory landscape, and future prospects.

By understanding Brazil’s capabilities, stakeholders can leverage its resources to drive medical advancements and contribute to the improvement of global healthcare.

Brazil’s Clinical Trials Market: Strengths and Advantages

Brazil’s clinical trials market has witnessed significant growth in recent years, fueled by several strengths and advantages.

One of Brazil’s key strengths is its large and diverse patient population, encompassing different ethnicities, genetic backgrounds, and disease prevalence. This diversity allows for more representative and robust study results, facilitating the generalizability of trial findings to broader populations.

Moreover, Brazil boasts a well-developed healthcare infrastructure, including renowned hospitals, research centers, and academic institutions. These institutions provide access to state-of-the-art facilities, experienced investigators, and a skilled workforce, enhancing the quality and credibility of clinical trials conducted in the country.

Additionally, Brazil’s geographic location in South America provides strategic advantages. Its proximity to neighboring countries fosters regional collaborations, enabling multinational studies and expanding the reach of clinical trials.

Furthermore, Brazil’s competitive costs in terms of trial operations, patient recruitment, and investigator fees make it an appealing option for sponsors and contract research organizations (CROs) seeking cost-effective research solutions.

Clinical Trials Market in Brazil

Clinical Trials Market in Brazil

Clinical Trials Market in Brazil

Regulatory Framework and Ethical Considerations

Brazil has established a comprehensive regulatory framework for clinical trials to ensure participant safety, data integrity, and ethical conduct. The National Health Surveillance Agency (ANVISA) serves as the regulatory authority responsible for overseeing and approving clinical research in Brazil. ANVISA’s regulatory processes align with international standards, including Good Clinical Practice (GCP), ensuring adherence to rigorous guidelines.

The regulatory process in Brazil involves the submission and review of study protocols, informed consent forms, and importation permits for investigational products. ANVISA employs efficient review timelines and a risk-based approach to trial oversight, streamlining the approval process while maintaining high standards of quality and participant protection.

Ethical considerations are paramount in clinical trials, and Brazil has robust systems in place to ensure the welfare of participants. Institutional Review Boards (IRBs), known as Ethics Committees (ECs), play a vital role in evaluating and approving trial protocols, monitoring participant safety, and upholding ethical standards. ECs ensure that trials prioritize participant well-being, informed consent processes, and compliance with ethical guidelines.

Notable Trends and Opportunities

The clinical trials market in Brazil is witnessing notable trends and offering exciting opportunities for stakeholders involved in medical research. One significant trend is the increasing focus on tropical diseases and infectious diseases.

Brazil’s unique geographic location and high prevalence of diseases such as dengue fever, Zika virus, and Chagas disease position it as a key hub for studying, understanding, and developing treatments for these diseases. This emphasis on tropical diseases contributes to global efforts in combating and eradicating diseases that predominantly affect tropical regions.

Another noteworthy trend is the growing interest in innovative therapies and advanced medical technologies. Brazil’s renowned research institutions and skilled healthcare professionals enable the country to actively participate in cutting-edge research, including gene therapies, cell-based therapies, and precision medicine.

The growing investment in these areas fosters scientific innovation, attracts international collaborations, and positions Brazil at the Forefront of medical advancements.

Additionally, Brazil is witnessing an increased emphasis on patient-centric clinical trials. There is a growing recognition of the importance of patient engagement, involvement, and inclusion in the trial design and decision-making process. This trend aims to improve participant recruitment and retention rates, enhance the relevance and applicability of trial outcomes, and ultimately, benefit patient populations.

Clinical Trials Market in Brazil

Source: Duke Clinical Research Institute

Patient Enrollment in Clinical Trials in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials Market in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials Market in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials Market in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials Market in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials Market in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials Market in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials Market in Brazil

The Cohortias Team

Clinical Trials Market in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials Market in Brazil

Network & Partnerships